Biotricity surpasses $10 million in annual revenue run rate
REDWOOD CITY, Calif., Nov 21, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity provides updates on its operational and expansion strategy
REDWOOD CITY, Calif., Nov 18, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity signs Distribution Agreement to expand access for its Cardiac Monitoring Solutions
REDWOOD CITY, Calif., Nov 16, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity reports financial results for Fiscal 2023 Second Quarter
REDWOOD CITY, Calif., Nov 14, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity’s Bioheart named to TIME’s list of The Best Inventions of 2022
REDWOOD CITY, Calif., Nov 10, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity to host Fiscal 2023 Second Quarter financial results on November 14th at 4:30 PM ET
REDWOOD CITY, Calif., Nov 01, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity launches Cardiac Disease Management Solution following 2 successful pilots with Oklahoma & Kentucky Clinics
REDWOOD CITY, Calif., Oct 26, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity CEO, Waqaas Al-Siddiq, to participate in panel discussion on the evolution of medical devices at the American Medical Device Summit on October 19th
REDWOOD CITY, Calif., Oct 11, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity surpasses 2 billion recorded and analyzed heartbeats for atrial fibrillation (AFib)
REDWOOD CITY, Calif., Oct 04, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity wins NIH Grant from the National Heart, Blood, and Lung Institute for AI-Enabled real-time monitoring and predictive analytics for stroke due to chronic kidney failure
REDWOOD CITY, Calif., Sep 07, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity reports financial results for Fiscal 2023 First Quarter
REDWOOD CITY, Calif., Aug 15, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), ("Biotricity" or the "Company"), a medical diagnostic and…
Biotricity to host Fiscal First Quarter 2023 financial results conference call on August 15th at 4:30 p.m. ET
REDWOOD CITY, Calif., Aug 05, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…